ADCT

ADC Therapeutics (ADCT) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.

SEC Filings

Bain Capital Life Sciences Fund Reports 9.99% Passive Stake In ADC Therapeutics

The fund counts warrants toward the position, and a blocker stops it from crossing 9.99% of the shares outstanding.

Earnings

ADC Therapeutics Plans $86.6 Million Share Sale, Cuts Loan To $50.0 Million, Drops $150 Million Change-Of-Control Payment

The company says the package extends its expected cash runway into 2029, and it gave preliminary third-quarter ZYNLONTA revenue of about $21.0 million.